BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37051525)

  • 1. Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database.
    Wang Q; Zhang L; Li H; Liu L; Sun X; Liu H
    Front Oncol; 2023; 13():1099117. PubMed ID: 37051525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature.
    Conforti F; Tarantino P; Trillo P; Pala L; Zagami P; Pirola S; Di Venosa B; Catania C; Queirolo P; Pennacchioli E; Della Vigna P; Curigliano G; De Pas TM
    Cancer Treat Rev; 2021 Jan; 92():102133. PubMed ID: 33296826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
    Xiaochuan L; Jiangyong Y; Ping Z; Xiaonan W; Lin L
    Thorac Cancer; 2020 Jun; 11(6):1522-1532. PubMed ID: 32301286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological and molecular features of pulmonary enteric adenocarcinoma].
    Gao G; Wang YZ; Zhang YP; Feng SE; Hou M; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):544-549. PubMed ID: 32486530
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and treatment of primary pulmonary enteric adenocarcinoma: Report of Six cases.
    Tu LF; Sheng LY; Zhou JY; Wang XF; Wang YH; Shen Q; Shen YH
    World J Clin Cases; 2021 Oct; 9(30):9236-9243. PubMed ID: 34786410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A Propensity Score Matching Study of Autologous Hematopoietic Stem Cell Transplantation and New Drug Chemotherapy for Newly Diagnosed Multiple Myeloma].
    Yang FY; Wang HF; Xia LH; Wang QQ; Qian CJ; He J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):158-165. PubMed ID: 35123620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
    Zhao H; Chen J
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.
    Chen Z; Liu J; Min L
    BMC Pulm Med; 2022 Mar; 22(1):116. PubMed ID: 35361152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of immunotherapy in
    Peng L; Guo J; Kong L; Huang Y; Tang N; Zhang J; Wang M; He X; Li Z; Peng Y; Wang Z; Han X
    Front Oncol; 2022; 12():1070761. PubMed ID: 36741723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 11. [Survival and prognosis analysis of patients with Hodgkin lymphoma treated with standard treatment paradigm].
    Shi YK; Tao XH; He Y; Qin P; Liu ST; Zhou JL; Yang LJ; Zhou YW; Song SL; Wang J; Jin H; Fang YP; Liu Y; Zhang SN; Qi Y; Yang CG; Zhang C; Yang L; Gui L
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(41):3295-3303. PubMed ID: 36319182
    [No Abstract]   [Full Text] [Related]  

  • 12. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
    Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
    JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.
    Xie M; Chen D; Li Y; Liu X; Kuang D; Li X
    Diagn Pathol; 2022 Feb; 17(1):30. PubMed ID: 35172862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic evaluation of esophageal cancer patients with stages I-III.
    Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
    Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
    Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
    Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer.
    Wang NF; Tang HM; Liu FL; Hong QY
    Chin Med J (Engl); 2020 Apr; 133(7):786-791. PubMed ID: 32195672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis.
    Sun Y; Wu M; Zhou M; Luo X; Guo Y; Bai H; Zhang Z; Tian W; Wang X; Bai Y; Zhu X; Pan H; Deng Y; Hu H; Xia J; Hao X; Han L; Wei M; Liu Y; Zeng M
    BMC Cancer; 2020 Jul; 20(1):646. PubMed ID: 32660443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2).
    Cadranel J; Mauguen A; Faller M; Zalcman G; Buisine MP; Westeel V; Longchampt E; Wislez M; Coudert B; Daniel C; Chetaille B; Michiels S; Blons H; Solassol J; De Fraipont F; Foucher P; Urban T; Lacroix L; Poulot V; Quoix E; Antoine M; Danton G; Morin F; Chouaid C; Pignon JP
    J Thorac Oncol; 2012 Oct; 7(10):1490-502. PubMed ID: 22982650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Poorly Differentiated Histology on Immunotherapy in Advanced Gastrointestinal Cancers.
    Draper A; Jung EH; Cao Y; Atallah RP; Switchenko J; Kane S; Guadagno J; Jones AT; Brutcher E; Alese OB
    Oncology; 2023; 101(4):213-223. PubMed ID: 36626879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.